Opinion
Accepted on 19 Nov 2025
Commentary: Clinical efficacy of plasmid encoding p62/SQSTM1 (Elenagen) in combination with gemcitabine in patients with platinum-resistant ovarian cancer: a randomized controlled trial
in Gynecological Oncology
Opinion
Accepted on 19 Nov 2025
in Gynecological Oncology
Case Report
Accepted on 19 Nov 2025
in Gastrointestinal Cancers: Colorectal Cancer
Correction
Accepted on 19 Nov 2025
in Thyroid Endocrinology
Original Research
Accepted on 19 Nov 2025
in Food Microbiology
Policy and Practice Reviews
Accepted on 19 Nov 2025
in Diabetes Multiorgan Complications
Original Research
Accepted on 19 Nov 2025
in Intensive Care Medicine and Anesthesiology
Editorial
Accepted on 19 Nov 2025
in Disease Prevention and Control Policy
Case Report
Accepted on 19 Nov 2025
in Infectious Diseases: Pathogenesis and Therapy
Original Research
Accepted on 19 Nov 2025
in Translational Medicine
Original Research
Accepted on 19 Nov 2025
in Space Physics
Editorial
Accepted on 19 Nov 2025
in Tropical Disease Epidemiology and Ecology
Original Research
Accepted on 19 Nov 2025
in Aquatic Microbiology
Original Research
Accepted on 19 Nov 2025
in Inflammation
Original Research
Accepted on 19 Nov 2025
in Optics and Photonics
Case Report
Accepted on 19 Nov 2025
in Parasitology
Original Research
Accepted on 19 Nov 2025
in Pulmonary Medicine